Automated Insulin Delivery System Safely Lowers A1c in Adults With Type 2 Diabetes Using Insulin
Researchers of a recent single-arm prospective trial evaluated the safety and efficacy of the Omnipod 5 automated insulin delivery (AID) system in adults with type 2 diabetes using insulin.
Researchers Link Semaglutide to Slightly Increased Risk of Rare Vision Loss
A new study has found that people taking semaglutide may face a slightly increased risk of developing nonarteritic anterior ischemic optic neuropathy (NAION), a rare condition that causes sudden vision loss in one eye due to reduced blood flow to the optic nerve.
Empagliflozin Lowers Cardiovascular Death and Mortality in High-Risk Patients With Type 2 Diabetes
Researchers of a large, randomized trial evaluated the cardiovascular effects of empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, in patients with type 2 diabetes at high cardiovascular risk.
Spinal Cord Stimulation: A Promising Solution for Pain Relief in Diabetic Peripheral Neuropathy
Spinal cord stimulation (SCS) has emerged as an effective treatment for managing pain from diabetic peripheral neuropathy (DPN), especially when other therapies are ineffective.
Diabetes Treatment Guidelines for Older Adults: Tailoring Care Based on Health, Aging, and Comorbidities
This guideline provides clinical practice guidance for treating diabetes in older adults, particularly those over the age of 65, as type 2 diabetes is becoming more prevalent in this age group.
Study Shows Automated Insulin Delivery System Betters Glycemic Control in Pediatric Type 1 Diabetes
A recent study published in Diabetes, Obesity and Metabolism shows that initiating an automated insulin delivery (AID) system improves glycemic control in children and adolescents with type 1 diabetes (T1D) who struggle to achieve optimal control with traditional methods.
Revised Approaches for Diabetes Overtreatment in Older Patients With Type 2 Diabetes
Recent clinical guidelines recommend avoiding “diabetes overtreatment” in older individuals with type 2 diabetes (T2D), which refers to excessively low glycemia that increases the risk of side effects like hypoglycemia.
FDA Updates “Healthy” Label Criteria to Support Healthy Eating Patterns and Promote Health Equity
The FDA has updated the criteria for the “healthy” nutrient content claim to help consumers identify foods that align with dietary recommendations. This claim, which manufacturers can voluntarily use, provides a quick signal on food labels to help consumers choose foundational foods for healthy eating patterns.
